Changes in ANA Positivity Following SARS‐CoV‐2 Outbreak in Lombardy Region, Italy
Journal of Medical Virology · 2026-04 · 98 (4)
DOI: 10.1002/jmv.70927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 13.04.2026. Verfasst von Eugenio Capparelli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, ASST Ovest Milanese, Legnano Hospital, Milan, Legnano, Italy. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Antibodies, Antinuclear. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The Coronavirus Disease 2019 (COVID‐19) pandemic has raised concerns regarding its potential to induce autoimmune responses. Antinuclear antibodies (ANA) are hallmarks of systemic autoimmunity, and emerging evidence suggests their increased prevalence post‐infection. This study aimed to assess ANA positivity rates and patterns of distribution before and after the onset of the pandemic in Lombardy, Italy. We conducted a historical analysis of 1879 matched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) – Reverse Transcription Polymerase Chain Reaction (RT‐PCR) and ANA records performed between March 2020 and December 2023. ANA positivity was assessed using indirect immunofluorescence (IIF) on Human Epithelial type 2 (HEp‐2) cells and classified according to the International Consensus on ANA Patterns (ICAP). The extracted data were compared to the pre‐pandemic period (2019). Cumulative risk analysis and Cox regression were used to evaluate associations among ANA and SARS‐CoV‐2 exposure, hospitalization, sex, and age. ANA positivity increased during the pandemic (42.4%) compared to 2019 (29.9%, p < 0.00001). Among SARS‐CoV‐2 positive individuals, ANA positivity was more frequent (12.9% vs 6%, OR: 2.31, p < 0.001). Cox regression confirmed that SARS‐CoV‐2 infection (HR:1.397), female sex (HR:1.458), hospitalization (HR 5.369) and age (HR:1.003) were independently associated with the risk of ANA positivity. Time‐to‐event analysis revealed that ANA positivity risk was higher in the first pandemic phases, following original and alfa variants of SARS‐CoV‐2 infections compared to delta and omicron variants. Nuclear anti‐topo I‐like [anti‐cell (AC)−29] pattern was more prevalent in SARS‐CoV‐2 positive individuals. SARS‐CoV‐2 infection is associated with an increased cumulative risk of ANA positivity in the Lombardy population, especially in the earlier phases of the pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rheumatology Unit, ASST Ovest Milanese, Legnano Hospital, Milan, Legnano, Italy.
- Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
- Laboratory of Clinical Chemistry, ASST Ovest Milanese, Hospital of Legnano, Milan, Legnano, Italy.
- Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy.
- Unit of Microbiology, ASST Ovest Milanese, Legnano Hospital, Milan, Legnano, Italy.
- NanoBioLab, Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy.
ORCID-Profile: Eugenio Capparelli, Massimo De Paschale
Zitieren
APA
Capparelli, E., Maggiolini, D., Paschale, M., Pavia, C., Faggioli, P., Colombo, M., Chimenti, M. S., Finazzi, S., & Mazzone, A. (2026). Changes in ANA Positivity Following SARS‐CoV‐2 Outbreak in Lombardy Region, Italy. Journal of Medical Virology, 98(4). https://doi.org/10.1002/jmv.70927
Vancouver
Capparelli E, Maggiolini D, Paschale M, Pavia C, Faggioli P, Colombo M, et al. Changes in ANA Positivity Following SARS‐CoV‐2 Outbreak in Lombardy Region, Italy. Journal of Medical Virology. 2026;98(4). doi:10.1002/jmv.70927
BibTeX
@article{Capparelli2026,
author = {Capparelli, Eugenio and Maggiolini, Dennis and Paschale, Massimo De and Pavia, Claudia and Faggioli, Paola and Colombo, Miriam and Chimenti, Maria Sole and Finazzi, Sergio and Mazzone, Antonino},
title = {Changes in ANA Positivity Following SARS‐CoV‐2 Outbreak in Lombardy Region, Italy},
journal = {Journal of Medical Virology},
year = {2026},
volume = {98},
number = {4},
doi = {10.1002/jmv.70927}
}
EUVIMED